<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font20 { font-size : 20; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font27">for </span>
   <span class="font26">the </span>
   <span class="font20">with </span>
   <span class="font17">HCQ </span>
   <span class="font17">patients </span>
   <span class="font16">was </span>
   <span class="font15">trial </span>
   <span class="font15">were </span>
   <span class="font14">viral </span>
   <span class="font14">COVID- </span>
   <span class="font14">(nÂ </span>
   <span class="font14">The </span>
   <span class="font14">not </span>
   <span class="font13">clinical </span>
   <span class="font13">study </span>
   <span class="font13">treatment </span>
   <span class="font13">chloroquine </span>
   <span class="font13">{background </span>
   <span class="font13">controlled </span>
   <span class="font13">group </span>
   <span class="font13">infection </span>
   <span class="font13">studies </span>
   <span class="font13">from </span>
   <span class="font13">are </span>
   <span class="font12">Clinical </span>
   <span class="font12">coronavirus </span>
   <span class="font12">mg/d </span>
   <span class="font12">antiviral </span>
   <span class="font12">significant </span>
   <span class="font12">[]. </span>
   <span class="font12">randomized </span>
   <span class="font12">have </span>
   <span class="font12">this </span>
   <span class="font12">margin </span>
   <span class="font12">risk </span>
   <span class="font12">Chinese </span>
   <span class="font12">Registry </span>
   <span class="font12">bias </span>
   <span class="font12">confirmed </span>
   <span class="font12">days </span>
   <span class="font12">{border-style </span>
   <span class="font12">Trials </span>
   <span class="font12">day </span>
   <span class="font12">etÂ </span>
   <span class="font12">evidence </span>
   <span class="font12">other </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">HIV </span>
   <span class="font12">None </span>
   <span class="font12">[], </span>
   <span class="font12">load </span>
   <span class="font12">novel </span>
   <span class="font12">pneumonia </span>
   <span class="font12">that </span>
   <span class="font11">any </span>
   <span class="font11">cell </span>
   <span class="font11">had </span>
   <span class="font11">hydroxychloroquine </span>
   <span class="font11">severe </span>
   <span class="font11">two </span>
   <span class="font11">ChiCTR </span>
   <span class="font11">count </span>
   <span class="font11">(COVID-) </span>
   <span class="font11">There </span>
   <span class="font11">clearance </span>
   <span class="font11">control </span>
   <span class="font11">difference </span>
   <span class="font11">more </span>
   <span class="font11">placebo </span>
   <span class="font11">all </span>
   <span class="font11">benefit </span>
   <span class="font11">chikungunya </span>
   <span class="font11">dengue </span>
   <span class="font11">either </span>
   <span class="font11">infections </span>
   <span class="font11">time </span>
   <span class="font11">trials </span>
   <span class="font11">weeks </span>
   <span class="font11">acute </span>
   <span class="font11">al., </span>
   <span class="font11">but </span>
   <span class="font11">received </span>
   <span class="font11">HCV </span>
   <span class="font11">adverse </span>
   <span class="font11">authors </span>
   <span class="font11">available </span>
   <span class="font11">disease </span>
   <span class="font11">enrolled </span>
   <span class="font11">these </span>
   <span class="font11">used </span>
   <span class="font11">virologically </span>
   <span class="font11">virus </span>
   <span class="font11">which </span>
   <span class="font11">Group </span>
   <span class="font11">TableÂ </span>
   <span class="font11">after </span>
   <span class="font11">also </span>
   <span class="font11">assessed </span>
   <span class="font11">double-blind </span>
   <span class="font11">fever </span>
   <span class="font11">one </span>
   <span class="font11">phosphate </span>
   <span class="font11">sample </span>
   <span class="font11">size </span>
   <span class="font11">statistically </span>
   <span class="font11">therapy </span>
   <span class="font11">versus </span>
   <span class="font11">viraemia </span>
   <span class="font11">â€" </span>
   <span class="font11">RCT </span>
   <span class="font11">Randomized, </span>
   <span class="font11">agents </span>
   <span class="font11">effect </span>
   <span class="font11">events </span>
   <span class="font11">randomized, </span>
   <span class="font11">significantly </span>
   <span class="font11">using </span>
   <span class="font10">RCTs </span>
   <span class="font10">This </span>
   <span class="font10">activation </span>
   <span class="font10">chronic </span>
   <span class="font10">each </span>
   <span class="font10">first </span>
   <span class="font10">higher </span>
   <span class="font10">immune </span>
   <span class="font10">increase </span>
   <span class="font10">infection. </span>
   <span class="font10">later </span>
   <span class="font10">may </span>
   <span class="font10">mild </span>
   <span class="font10">open-label, </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">plus </span>
   <span class="font10">px; </span>
   <span class="font10">results </span>
   <span class="font10">vitro </span>
   <span class="font10">whether </span>
   <span class="font10">{font-family </span>
   <span class="font10">)Group </span>
   <span class="font10">HIV-infected </span>
   <span class="font10">Two </span>
   <span class="font10">al. </span>
   <span class="font10">clinically </span>
   <span class="font10">combination </span>
   <span class="font10">double-blind, </span>
   <span class="font10">due </span>
   <span class="font10">efficacy </span>
   <span class="font10">font-size </span>
   <span class="font10">hepatitis </span>
   <span class="font10">included </span>
   <span class="font10">inÂ </span>
   <span class="font10">non-randomized </span>
   <span class="font10">only </span>
   <span class="font10">open-label </span>
   <span class="font10">receive </span>
   <span class="font10">ribavirin </span>
   <span class="font10">same </span>
   <span class="font10">small </span>
   <span class="font10">such </span>
   <span class="font10">than </span>
   <span class="font10">Adult </span>
   <span class="font10">However, </span>
   <span class="font10">Patients </span>
   <span class="font10">RNA </span>
   <span class="font10">Randomized </span>
   <span class="font10">[,] </span>
   <span class="font10">against </span>
   <span class="font10">animal </span>
   <span class="font10">antiretroviral </span>
   <span class="font10">arm </span>
   <span class="font10">attrition </span>
   <span class="font10">calculation </span>
   <span class="font10">decrease </span>
   <span class="font10">double; </span>
   <span class="font10">drug </span>
   <span class="font10">duration </span>
   <span class="font10">evaluated </span>
   <span class="font10">followed </span>
   <span class="font10">given </span>
   <span class="font10">group, </span>
   <span class="font10">human </span>
   <span class="font10">illness </span>
   <span class="font10">noted </span>
   <span class="font10">prospective, </span>
   <span class="font10">published </span>
   <span class="font10">reduction </span>
   <span class="font10">reported </span>
   <span class="font10">role </span>
   <span class="font10">suspected </span>
   <span class="font10">use </span>
   <span class="font10">without </span>
   <span class="font10">(RT-PCR) </span>
   <span class="font10">ART </span>
   <span class="font10">ClinicalTrials.gov </span>
   <span class="font10">Elsevier </span>
   <span class="font10">For </span>
   <span class="font10">High </span>
   <span class="font10">MedRxiv </span>
   <span class="font10">NCT </span>
   <span class="font10">Study </span>
   <span class="font10">These </span>
   <span class="font10">according </span>
   <span class="font10">agent </span>
   <span class="font10">antivirals </span>
   <span class="font10">articles </span>
   <span class="font10">base/d </span>
   <span class="font10">been </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">care </span>
   <span class="font10">cure </span>
   <span class="font10">curing </span>
   <span class="font10">dengue, </span>
   <span class="font10">didanosine </span>
   <span class="font10">faster </span>
   <span class="font10">full-text </span>
   <span class="font10">groups </span>
   <span class="font10">levels </span>
   <span class="font10">lopinavir/ritonavir </span>
   <span class="font10">months </span>
   <span class="font10">now </span>
   <span class="font10">outcomes </span>
   <span class="font10">peer-reviewed </span>
   <span class="font10">persistent </span>
   <span class="font10">prevention </span>
   <span class="font10">prospective </span>
   <span class="font10">radiological </span>
   <span class="font10">search </span>
   <span class="font10">solid; </span>
   <span class="font10">standard </span>
   <span class="font10">studies, </span>
   <span class="font10">suppression </span>
   <span class="font10">test </span>
   <span class="font10">treatmentâ€™ </span>
   <span class="font10">within </span>
   <span class="font10">zidovudine </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">â€˜standard </span>
   <span class="font10">&amp;gt;/Î¼L </span>
   <span class="font10">AND </span>
   <span class="font10">COVID-. </span>
   <span class="font10">Chikungunya </span>
   <span class="font10">China </span>
   <span class="font10">China, </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">Cochrane </span>
   <span class="font10">Dis </span>
   <span class="font10">HCQ. </span>
   <span class="font10">IFN </span>
   <span class="font10">Risk </span>
   <span class="font10">Ther </span>
   <span class="font10">USA </span>
   <span class="font10">Virol </span>
   <span class="font10">[,]. </span>
   <span class="font10">above </span>
   <span class="font10">absolute </span>
   <span class="font10">adults </span>
   <span class="font10">analysis </span>
   <span class="font10">assessing </span>
   <span class="font10">beneficial </span>
   <span class="font10">between </span>
   <span class="font10">bold </span>
   <span class="font10">cells </span>
   <span class="font10">centre </span>
   <span class="font10">change </span>
   <span class="font10">children </span>
   <span class="font10">comparators </span>
   <span class="font10">considered </span>
   <span class="font10">courier; </span>
   <span class="font10">daily </span>
   <span class="font10">days) </span>
   <span class="font10">detection </span>
   <span class="font10">did </span>
   <span class="font10">discussed </span>
   <span class="font10">drugs </span>
   <span class="font10">early </span>
   <span class="font10">effective </span>
   <span class="font10">effects </span>
   <span class="font10">em; </span>
   <span class="font10">emerging </span>
   <span class="font10">evidence). </span>
   <span class="font10">group. </span>
   <span class="font10">has </span>
   <span class="font10">high </span>
   <span class="font10">improvement </span>
   <span class="font10">increased </span>
   <span class="font10">interferon </span>
   <span class="font10">likely </span>
   <span class="font10">over </span>
   <span class="font10">per </span>
   <span class="font10">performance </span>
   <span class="font10">pilot </span>
   <span class="font10">preprints </span>
   <span class="font10">preprints) </span>
   <span class="font10">pt;} </span>
   <span class="font10">reduced </span>
   <span class="font10">resource </span>
   <span class="font10">respiratory </span>
   <span class="font10">selection </span>
   <span class="font10">similar </span>
   <span class="font10">strategy </span>
   <span class="font10">supported </span>
   <span class="font10">terms </span>
   <span class="font10">their </span>
   <span class="font10">they </span>
   <span class="font10">tolerated </span>
   <span class="font10">total </span>
   <span class="font10">unclear </span>
   <span class="font10">virological </span>
   <span class="font10">well </span>
   <span class="font10">while </span>
  </p>
 </body>
</html>
